Clinical Trials Logo

Filter by:
NCT ID: NCT00450203 Recruiting - Clinical trials for Oesophagogastric Cancer

Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer

ST03
Start date: October 2007
Phase: Phase 2/Phase 3
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as epirubicin, cisplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Monoclonal antibodies, such as bevacizumab, and small molecule tyrosine kinase inhibitors, such as lapatinib, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Bevacizumab may also stop the growth of tumor cells by blocking blood flow to the tumor. Lapatinib targets a specific growth receptor, HER-2. Chemotherapy together with bevacizumab or lapatinib, in HER-2 positive tumours, may kill more tumor cells. PURPOSE: This randomized phase II/III trial is studying the side effects and how well giving combination chemotherapy together with bevacizumab works compared with combination chemotherapy alone in treating patients with previously untreated stomach cancer, gastroesophageal junction cancer or lower oesophageal cancer that can be removed by surgery. The feasibility study is studying the safety of adding lapatinib to chemotherapy in patients with HER-2 positive previously untreated stomach cancer, gastroesophageal junction cancer or lower oesophageal cancer that can be removed by surgery. The feasibility study will also assess the feasibility of timely HER-2 testing and estimate the HER-2 positivity rate in this patient population.

NCT ID: NCT00445783 Recruiting - Melanoma (Skin) Clinical Trials

Study of Families With Melanoma

Start date: July 2000
Phase: N/A
Study type: Observational

RATIONALE: A study that evaluates patients' lifestyle, skin, and blood and tissue samples may help doctors understand the risk factors for melanoma relapse. PURPOSE: This clinical trial is studying the risk factors for melanoma in families with melanoma.

NCT ID: NCT00445497 Recruiting - Lymphoma Clinical Trials

Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia

Start date: July 2007
Phase: Phase 3
Study type: Interventional

RATIONALE: Finishing an antibiotic regimen at home may be as effective as receiving it in the hospital. It is not yet known whether early hospital discharge is as effective as standard inpatient care in cancer patients receiving antibiotics for febrile neutropenia. PURPOSE: This randomized phase III trial is studying early hospital discharge and comparing it with standard inpatient care in cancer patients receiving antibiotics for febrile neutropenia.

NCT ID: NCT00436774 Recruiting - Ovarian Cancer Clinical Trials

Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01

Start date: June 2006
Phase: N/A
Study type: Observational

RATIONALE: Treatment for pediatric extracranial germ cell tumors may cause side effects and secondary cancers later in life. A study that evaluates patients after receiving combination chemotherapy or surgery may help doctors understand the side effects and secondary cancers that occur later in life. PURPOSE: This study is looking at treatment outcome and quality of life in patients with pediatric extracranial germ cell tumors previously treated on clinical trial CCLG-GC-1979-01 or CCLG-GC-1989-01.

NCT ID: NCT00429897 Recruiting - Clinical trials for Low-Renin Hypertension

Double Blind Crossover Comparison of Diuretics in the Young

Start date: August 2006
Phase: N/A
Study type: Interventional

The principle objective of the study is to determine whether low-renin (i.e. salt sensitive) hypertension at a young age is caused by the kidneys hanging onto too much salt as a result of an over active salt pump in the kidney. The kidneys have four different salt pumps, and each is blocked by a different type of diuretic (salt losing tablet)If one out of the four is overactive, we would expect patients to respond much better to one diuretic than to the alternatives - rather than responding equally well to all available types of diuretic.

NCT ID: NCT00426335 Recruiting - Breast Cancer Clinical Trials

Evaluation of Group CBT Programme With Breast Cancer Patients

Start date: January 2007
Phase: Phase 0
Study type: Observational

The purpose of this study is to examine whether a group CBT intervention is effective in reducing psychological distress in women with primary breast cancer.

NCT ID: NCT00423280 Recruiting - Clinical trials for Coronary Artery Disease

Effect of 6R-BH4 Treatment in Coronary Artery Disease (OXBIO Study)

Start date: November 2006
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the effect of 6R-BH4 on vascular function in patients with coronary artery disease. We hypothesize that 6R-BH4 will improve vascular function in these patients.

NCT ID: NCT00415935 Recruiting - Clinical trials for Juvenile Idiopathic Arthritis

PRINTO (the Paediatric Rheumatology International Trials Organisation)

Start date: n/a
Phase: N/A
Study type: Observational

A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months

NCT ID: NCT00415727 Recruiting - Sickle Cell Anaemia Clinical Trials

Prevention Of Morbidity In Sickle Cell Disease Pilot Phase

Start date: November 2006
Phase: Phase 2
Study type: Interventional

The hypothesis is that in sickle cell anaemia, nocturnal oxyhaemoglobin desaturation, is associated with low processing speed index, and this morbidity can be reduced with overnight auto Continuous Positive Airways Pressure and/or oxygen supplementation.

NCT ID: NCT00403143 Recruiting - Blindness Clinical Trials

Do Blue-Blocking Lenses Block Blue Colour From Our Lives?

Start date: October 2006
Phase: N/A
Study type: Interventional

To measure colour vision in patients with a blue light filtering lens implant in one eye and non-tinted implant in the other eye (and compared this group with a control group with bilateral non-tinted implants) and to determine whether blue light filtering lenses limit colour vision